Rite Aid Corp. (RAD)

6.30
NYSE : Retail Trade
Prev Close 6.67
Day Low/High 6.25 / 6.70
52 Wk Low/High 6.36 / 42.40
Avg Volume 8.81M
Exchange NYSE
Shares Outstanding 53.83M
Market Cap 359.04M
EPS -15.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Walgreen Likely to Raise Dividend

Walgreen Likely to Raise Dividend

Drugstore retailer Walgreen will likely boost its dividend in July, says Portfolio Manager David Peltier.

No Compelling Reason to Own Walgreen

If shares fall to under $40, I would take another look.

FOMC Rate Decision Due This Week

FOMC Rate Decision Due This Week

It's a big week for economic events, with the FOMC rate decision taking center stage on Wednesday. Brittany Umar details the week ahead.

Pumped on GNC

Pumped on GNC

TheStreet hits the street at GNC, where Belus Capital Advisor CEO Brian Sozzi is pumped up on GNC.

Opportunity Among the Volatility

Opportunity Among the Volatility

Volatility has increased at the beginning of earnings season. Portfolio Manager David Peltier says where he find buying opportunities.

Microsoft Flops, Rite Aid Pops

Microsoft Flops, Rite Aid Pops

Microsoft slumps on a downgrade from Goldman Sachs, while Rite Aid pops on profits - TheStreet's Debra Borchardt details.

Alcoa, Family Dollar to Lead Earnings

Alcoa, Family Dollar to Lead Earnings

Earnings seasons begins next week with Alcoa, followed by retail. TheStreet's Brittany Umar runs down the schedule.

There at the Top?

There at the Top?

The significance of shrinking trading ranges.

Stocks Under $10: Live Twitter Chat

Stocks Under $10: Live Twitter Chat

Portfolio Mgr. David Peltier invites viewers to his monthly #SU10chat on Twitter.

Rite Aid rated new Buy at BTIG

CVS Has the Right Prescription

CVS Has the Right Prescription

Stephanie Link, director of research at TheStreet, likes CVS for more than the market share they are gaining from Walgreen.

Rite Aid target raised at UBS

Rite Aid Is Starting to Look Healthy

This is a risky long idea, but an intriguing one as well.

Buy This One Over the Counter

Buy This One Over the Counter

Walgreen is in tip-top shape, and it's unlikely to outright acquire the troubled Rite Aid.

Three More Long Shots for the Bold Investor

These dark horses that could surge ahead of the pack and pay off big.

Rite Aid numbers raised at Goldman

No Value in Junk

At current levels, these bonds just don't represent any real opportunities.